These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Clinical Outcome
7 results:

  • 1. A concise review on the role of BDNF-AS in human disorders.
    Ghafouri-Fard S; Khoshbakht T; Taheri M; Ghanbari M
    Biomed Pharmacother; 2021 Oct; 142():112051. PubMed ID: 34426254
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer.
    de Mey S; Jiang H; Wang H; Engels B; Gevaert T; Dufait I; Feron O; Aerts J; Verovski V; De Ridder M
    Radiother Oncol; 2018 Jun; 127(3):361-369. PubMed ID: 29871814
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.
    Kleist B; Poetsch M
    World J Gastroenterol; 2015 Nov; 21(41):11740-7. PubMed ID: 26556999
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.
    Sriraman SK; Geraldo V; Luther E; Degterev A; Torchilin V
    J Control Release; 2015 Dec; 220(Pt A):160-168. PubMed ID: 26497930
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus.
    Liu Y; Starr MD; Brady JC; Rushing C; Bulusu A; Pang H; Honeycutt W; Amara A; Altomare I; Uronis HE; Hurwitz HI; Nixon AB
    Mol Cancer Ther; 2015 Apr; 14(4):1048-56. PubMed ID: 25695956
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer.
    Hale JP; Cohen DR; Maughan TS; Stephens RJ
    Br J Cancer; 2002 Jun; 86(11):1684-90. PubMed ID: 12087450
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.